Showing results (7181-7190 of 10,083) with videos related to

Sort By:
Pageof 1,009
Current Pharmaceutical Design|April 21, 2020
Anticoagulation in Deep Venous Thrombosis: Current Trends in the Era of Non- Vitamin K Antagonists Oral AnticoagulantsPanteleimon E Papakonstantinou, Costas Tsioufis, Dimitris Konstantinidis, et al.
Current Pharmaceutical Design|April 19, 2020
Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological DisordersSaurabh Mittal, Muhammad U Ashhar, Farheen F Qizilbash, et al.
Current Pharmaceutical Design|April 19, 2020
Plant Extracts as a Natural Source of Bioactive Compounds and Potential Remedy for the Treatment of Certain Skin DiseasesPrzemysław Sitarek, Tomasz Kowalczyk, Joanna Wieczfinska, et al.
Current Pharmaceutical Design|April 19, 2020
Hepatoprotective Effects of Resveratrol in Non-Alcoholic Fatty Live DiseaseSilvia Tejada, Xavier Capó, Catalina Mª Mascaró, et al.
Current Pharmaceutical Design|March 17, 2023
Cancer Proteomics for Cellular Dysfunction: Insights and TrendsAnjna Rani, Veena Devi Singh, Rupa Mazumder, et al.
Current Pharmaceutical Design|March 17, 2023
Advances in the Management of Heart Failure with Reduced Ejection Fraction; The Role of SGLT2is, ARNI, Myotropes, Vericiguat, and Anti-inflammatory Agents: A Mini-reviewDimitrios A Vrachatis, Konstantinos A Papathanasiou, Sotiria G Giotaki, et al.
Current Pharmaceutical Design|January 31, 2023
Scutellarin Suppressed Proliferation and Induced Apoptosis in Gastric Cancer via Wnt/β-catenin Signaling PathwayZhenkai Wang, Xiang Liu, Wanzhen Chen, et al.
Current Pharmaceutical Design|February 24, 2023
Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A NephropathyHong-Bo Li, Jia-Lin Zhou, Pin-Peng Xie, et al.
Current Pharmaceutical Design|September 15, 2012
Anti-disease therapy for malaria - 'resistance proof'?Angus Bell, Daniela Boehm
Pageof 1,009